Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of intravenous buprenorphine in children.

Literature DB >> 2775626

Pharmacokinetics of intravenous buprenorphine in children.

K T Olkkola¹, E L Maunuksela, R Korpela.

Abstract

Buprenorphine (3 micrograms kg-1) was given intravenously as premedication to small children (age 4-7 years) undergoing minor surgery. Because of the rapid decline of the plasma buprenorphine concentrations, the terminal elimination half-life could not be estimated reliably. Given this constraint, values of clearance appeared to be higher than those in adults but values of Vss were similar.

Entities: Chemical Species

Mesh：

Substances：
Buprenorphine

Year: 1989 PMID： 2775626 PMCID： PMC1379907 DOI： 10.1111/j.1365-2125.1989.tb05418.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

7 in total

1. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1976-10

2. Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain of children.

Authors: E L Maunuksela; R Korpela; K T Olkkola
Journal: Br J Anaesth Date: 1988-01 Impact factor: 9.166

3. Statistical estimations in pharmacokinetics.

Authors: H G Boxenbaum; S Riegelman; R M Elashoff
Journal: J Pharmacokinet Biopharm Date: 1974-04

4. Comparison of buprenorphine with morphine in the treatment of postoperative pain in children.

Authors: E L Maunuksela; R Korpela; K T Olkkola
Journal: Anesth Analg Date: 1988-03 Impact factor: 5.108

5. Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis.

Authors: R E Bullingham; H J McQuay; E J Porter; M C Allen; R A Moore
Journal: Br J Clin Pharmacol Date: 1982-05 Impact factor: 4.335

6. Buprenorphine kinetics.

Authors: R E Bullingham; H J McQuay; A Moore; M R Bennett
Journal: Clin Pharmacol Ther Date: 1980-11 Impact factor: 6.875

7. The radioimmunoassay of buprenorphine.

Authors: A J Bartlett; J G Lloyd-Jones; M J Rance; I R Flockhart; G J Dockray; M R Bennett; R A Moore
Journal: Eur J Clin Pharmacol Date: 1980-10 Impact factor: 2.953

7 in total

8 in total

Review 1. [Buprenorphine in children. A clinical and pharmacological review].

Authors: E Michel; B Zernikow
Journal: Schmerz Date: 2006-02 Impact factor: 1.107

2. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.

Authors: Chee M Ng; Erin Dombrowsky; Hopi Lin; Michelle E Erlich; David E Moody; Jeffrey S Barrett; Walter K Kraft
Journal: Pharmacotherapy Date: 2015-07-14 Impact factor: 4.705

3. A mechanistic approach for the scaling of clearance in children.

Authors: Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal: Clin Pharmacokinet Date: 2006 Impact factor: 6.447

4. The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates.

Authors: D A Barrett; J Simpson; N Rutter; T Kurihara-Bergstrom; P N Shaw; S S Davis
Journal: Br J Clin Pharmacol Date: 1993-09 Impact factor: 4.335

5. Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.

Authors: Matthijs W van Hoogdalem; Trevor N Johnson; Brooks T McPhail; Suyog Kamatkar; Scott L Wexelblatt; Laura P Ward; Uwe Christians; Henry T Akinbi; Alexander A Vinks; Tomoyuki Mizuno
Journal: Clin Pharmacol Ther Date: 2021-11-21 Impact factor: 6.903